Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19Teresa H. Evering, Lara Hosey, Mark J Giganti et al.|Annals of Internal Medicine|2023Cited by 31
Long COVID After Bamlanivimab TreatmentTeresa H. Evering, Asha Kallianpur, Busola Sanusi et al.|The Journal of Infectious Diseases|2023Cited by 4